BioSpace News Archive

Lupin is pleased to announce that NaMuscla® (mexiletine) has been launched in Germany and the United Kingdom (UK).

Boston Scientific, a global medical technology company, has joined PracticePoint, a membership-based research and development and commercialization alliance founded by Worcester Polytechnic Institute (WPI) to advance healthcare and patient wellness technologies through accelerating development of medical cyber-physical systems.

Genetic testing improves the diagnoses of abnormalities in developing babies that are picked up during ultrasound scans, scientists report today (31 January) in The Lancet.

Patient safety advocates testified to the Medical Board of California that its initiative to investigate excessive prescribing by doctors involved in prescription overdose deaths is critical to state efforts to end the opioid overdose epidemic.

The Obesity Society Marks American Heart Month in February

Omnicell, Inc., a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, February 7, 2019, to discuss the Company’s Fourth Quarter 2018 financial results.

Dicerna Pharmaceuticals, Inc. announced that the Compensation Committee of the Company’s Board of Directors approved the grant of inducement stock options to purchase a total of 419,000 shares of common stock to be distributed among 14 new employees with a grant date of February 1, 2019.

You may be able to reduce the amount of federal tax you pay by claiming a non-refundable tax credit on a wide variety of medical expenses.

On February 1, 2019, the Federal Food and Drug Administration issued a public statement warning compounders “not to use glutathione-L-reduced powder distributed by Letco Medical, Decatur, Alabama, to compound sterile injectable drugs for patients.”